Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1971 2
1986 1
1987 1
1991 2
1992 2
1993 1
1994 2
1995 3
1996 3
1997 5
1998 6
1999 4
2000 4
2001 2
2002 2
2003 4
2004 5
2005 3
2006 1
2007 2
2008 4
2009 5
2010 4
2011 10
2012 2
2013 5
2014 4
2015 4
2016 6
2017 7
2018 5
2019 10
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

112 results
Results by year
Filters applied: . Clear all
Page 1
Rates and Outcomes of Parathyroidectomy for Secondary Hyperparathyroidism in the United States.
Kim SM, Long J, Montez-Rath ME, Leonard MB, Norton JA, Chertow GM. Kim SM, et al. Clin J Am Soc Nephrol. 2016 Jul 7;11(7):1260-7. doi: 10.2215/CJN.10370915. Epub 2016 Jun 6. Clin J Am Soc Nephrol. 2016. PMID: 27269300 Free PMC article.
In-hospital mortality rates were significantly higher in patients with heart failure (odds ratio [OR], 4.23; 95% CI, 2.59 to 6.91) and peripheral vascular disease (OR, 4.59; 95% CI, 2.75 to 7.65) and lower among patients with prior kidney transplantation (OR, 0.20; 95% CI, …
In-hospital mortality rates were significantly higher in patients with heart failure (odds ratio [OR], 4.23; 95% CI, 2.59 to 6.91) an …
Risk of Cardiovascular Disease and Mortality in Young Adults With End-stage Renal Disease: An Analysis of the US Renal Data System.
Modi ZJ, Lu Y, Ji N, Kapke A, Selewski DT, Dietrich X, Abbott K, Nallamothu BK, Schaubel DE, Saran R, Gipson DS. Modi ZJ, et al. JAMA Cardiol. 2019 Apr 1;4(4):353-362. doi: 10.1001/jamacardio.2019.0375. JAMA Cardiol. 2019. PMID: 30892557 Free PMC article.
Young adults (aged 22-29 years) had a 1-year CV hospitalization rate of 138 (95% CI, 121-159) per 1000 patient-years. Young adults had a higher risk for CV hospitalization than children (aged 1-11 years; hazard ratio [HR], 0.41 [95% CI, 0.26-0.64]) and adolescents (aged 12 …
Young adults (aged 22-29 years) had a 1-year CV hospitalization rate of 138 (95% CI, 121-159) per 1000 patient-years. Young adults ha …
In-Hospital Mortality and Major Adverse Cardiovascular Events after Kidney Transplantation in the United States.
Goyal A, Chatterjee K, Mathew RO, Sidhu MS, Bangalore S, McCullough PA, Rangaswami J. Goyal A, et al. Cardiorenal Med. 2019;9(1):51-60. doi: 10.1159/000492731. Epub 2018 Nov 14. Cardiorenal Med. 2019. PMID: 30428461 Free article. Clinical Trial.
Cardiovascular disease is a major determinant of morbidity and mortality in patients with KT. Temporal trends in perioperative cardiovascular outcomes after KT are understudied, especially in light of an aging KT waitlist population. ...Overall average perioperative
Cardiovascular disease is a major determinant of morbidity and mortality in patients with KT. Temporal trends in perioperative car
Renal Transplantation and Survival Among Patients With Lupus Nephritis: A Cohort Study.
Jorge A, Wallace ZS, Lu N, Zhang Y, Choi HK. Jorge A, et al. Ann Intern Med. 2019 Feb 19;170(4):240-247. doi: 10.7326/M18-1570. Epub 2019 Jan 22. Ann Intern Med. 2019. PMID: 30665236 Free PMC article.
Adjusted HRs for cause-specific mortality were 0.26 (CI, 0.23 to 0.30) for cardiovascular disease, 0.30 (CI, 0.19 to 0.48) for coronary heart disease, 0.41 (CI, 0.32 to 0.52) for infection, and 0.41 (CI, 0.31 to 0.53) for sepsis. ...CONCLUSION: Renal transplant was …
Adjusted HRs for cause-specific mortality were 0.26 (CI, 0.23 to 0.30) for cardiovascular disease, 0.30 (CI, 0.19 to 0.48) for corona …
Cause of death in patients with end-stage renal disease: death certificates vs registry reports.
Perneger TV, Klag MJ, Whelton PK. Perneger TV, et al. Am J Public Health. 1993 Dec;83(12):1735-8. doi: 10.2105/ajph.83.12.1735. Am J Public Health. 1993. PMID: 8259805 Free PMC article.
On the registry form, patient death was ascribed to 1 of 22 precoded causes by the patient's nephrologist of record. Corresponding death certificates were coded, according to rules of the International Classification of Diseases, 9th edition, by a trained observer u …
On the registry form, patient death was ascribed to 1 of 22 precoded causes by the patient's nephrologist of record. Correspon …
Kidney transplantation as a therapeutic option for end-stage renal disease developing after heart transplantation.
Grupper A, Grupper A, Daly RC, Pereira NL, Hathcock MA, Kremers WK, Cosio FG, Edwards BS, Kushwaha SS. Grupper A, et al. J Heart Lung Transplant. 2017 Mar;36(3):297-304. doi: 10.1016/j.healun.2016.08.004. Epub 2016 Aug 18. J Heart Lung Transplant. 2017. PMID: 27642059
BACKGROUND: Progressive renal failure is a frequent complication after heart transplantation (HTx). It may result in end-stage renal disease (ESRD), prompting consideration of kidney Tx after HTx (KAH). ...
BACKGROUND: Progressive renal failure is a frequent complication after heart transplantation (HTx). It may result in end-stage renal …
Heart-Kidney and Heart-Liver Transplantation Provide Immunoprotection to the Cardiac Allograft.
Chou AS, Habertheuer A, Chin AL, Sultan I, Vallabhajosyula P. Chou AS, et al. Ann Thorac Surg. 2019 Aug;108(2):458-466. doi: 10.1016/j.athoracsur.2019.02.012. Epub 2019 Mar 15. Ann Thorac Surg. 2019. PMID: 30885846 Clinical Trial.
METHODS: The United Network for Organ Sharing database for heart transplantation was queried from 1987 to 2015 and stratified into patients undergoing heart-liver transplantation (HLT) (n = 192), heart-kidney transplantation (HKT) (n = 1,174), and heart
METHODS: The United Network for Organ Sharing database for heart transplantation was queried from 1987 to 2015 and stratified into pa …
Use of durable mechanical circulatory support on outcomes of heart-kidney transplantation.
Chan JL, Patel DC, Megna D, Dimbil SJ, Levine R, Moriguchi J, Czer LS, Kobashigawa JA, Arabia F, Esmailian F. Chan JL, et al. Interact Cardiovasc Thorac Surg. 2018 Nov 1;27(5):773-777. doi: 10.1093/icvts/ivy156. Interact Cardiovasc Thorac Surg. 2018. PMID: 29846594
However, data on outcomes of patients with MCS who require simultaneous heart-kidney transplant are limited. METHODS: A retrospective review of simultaneous heart-kidney transplantations (HKTxs) performed at a single institution over a 5-year period was performed. . …
However, data on outcomes of patients with MCS who require simultaneous heart-kidney transplant are limited. METHODS: A retrospective …
Does DCD Donor Time-to-Death Affect Recipient Outcomes? Implications of Time-to-Death at a High-Volume Center in the United States.
Scalea JR, Redfield RR, Arpali E, Leverson GE, Bennett RJ, Anderson ME, Kaufman DB, Fernandez LA, D'Alessandro AM, Foley DP, Mezrich JD. Scalea JR, et al. Am J Transplant. 2017 Jan;17(1):191-200. doi: 10.1111/ajt.13948. Epub 2016 Aug 25. Am J Transplant. 2017. PMID: 27375072 Free article.
Five-year patient survival was 88.8% for group 1, and 83.9% for group 2 (p = 0.667); Graft survival was also similar, with 5-year survival of 74.1% for group 1, and 83.9% for group 2 (p = 0.507). ...
Five-year patient survival was 88.8% for group 1, and 83.9% for group 2 (p = 0.667); Graft survival was also similar, with 5-year sur …
Trends in the Causes of Death among Kidney Transplant Recipients in the United States (1996-2014).
Awan AA, Niu J, Pan JS, Erickson KF, Mandayam S, Winkelmayer WC, Navaneethan SD, Ramanathan V. Awan AA, et al. Am J Nephrol. 2018;48(6):472-481. doi: 10.1159/000495081. Epub 2018 Nov 23. Am J Nephrol. 2018. PMID: 30472701 Free PMC article.
Cardiovascular deaths constituted the majority (24.7%), followed by infectious (15.2%) and malignant (2.9%) causes; 40.1% of deaths had no reported cause. Using 1996 as the referent year, all-cause as well as cardiovascular mortality declined, whereas mortality due
Cardiovascular deaths constituted the majority (24.7%), followed by infectious (15.2%) and malignant (2.9%) causes; 40.1% of deaths h
112 results
Jump to page
Feedback